Member

With that in mind, I turn to some of the rhetoric that has come from the Government around this, and indeed some of the actions. I understand the argument about trials identified as low risk, particularly those using medicines that have already been approved for other purposes. But let us acknowledge that, historically, the use of some of our longest-serving medicines, medical devices and medical practice is often based on custom and practice rather than a strong foundation of evidence. It is important to make sure that what we are identifying as low risk really is low risk.